Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Timeline: Expected Clinical Trial Readouts For PD-1 Competitors

Executive Summary

Scrip highlights the top data readouts expected over the next 12 months from the big PD-1/PD-L1 players, such as Bristol Myers Squibb and Merck & Co. – as well as a few compounds to watch out for earlier in the cancer immunotherapy pipeline.

Advertisement

Related Content

Finance Watch: Former GSK CEO Witty, R&D Head Slaoui Join VC Firms
J.P. Morgan Executive Roundtable, Part 4: How Do You Determine A Drug’s Value To Patients, Payers, Partners?
J.P. Morgan Executive Roundtable, Part 3: Financing Is Difficult, But Available For Drugs That Provide Value
J.P. Morgan Executive Roundtable, Part 2: Women In Biopharma And The Path Forward
J.P. Morgan Executive Roundtable, Part 1: How To Help Women Move Into The Biopharma C-Suite

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097599

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel